TYRX: Study shows significant decline in cardiac infections with antibacterial envelope

TYRX: Study shows significant decline in cardiac infections with antibacterial envelope

DENVER - TYRX Inc . said its AIGISRx Antibacterial Envelope significantly reduced device infection rates in patients at high risk for device infection who received cardiovascular implantable... Read More

By: Steve Monday May 13, 2013 0 comments Tags: Denver, Dr. Suneet Mittal, Heart Rhythm 2013, TYRX